Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

tumor-infiltrating lymphocyte

  • Open Access
    Pancancer Landscape of Long Non-coding RNA Expression and Immune Status of the Tumor Microenvironment in Japanese Cancer Patients
    TOMOATSU IKEYA, YASUTO AKIYAMA, HARUO MIYATA, TADASHI ASHIZAWA, YASUFUMI KIKUCHI, AKIRA IIZUKA, CHIE MAEDA, AKARI KANEMATSU, KAZUE YAMASHITA, KENICHI URAKAMI, TAKESHI NAGASHIMA, KEIICHI OHSHIMA and KEN YAMAGUCHI
    Anticancer Research October 2025, 45 (10) 4315-4331; DOI: https://doi.org/10.21873/anticanres.17782
  • You have access
    Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer
    KANECHIKA DEN, TAKASHI MURAKAMI, RYUSEI MATSUYAMA, KENTARO MIYAKE, YUKI HOMMA, YASUHIRO YABUSHITA, RYUTARO MORI, YUKIHIKO HIROSHIMA, IKUMA KATO and ITARU ENDO
    Anticancer Research April 2025, 45 (4) 1731-1747; DOI: https://doi.org/10.21873/anticanres.17554
  • You have access
    CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
    NATSUKI UENAKA, EIICHI SATO, YOSHIYA HORIMOTO, SAORI KAWAI, MARIKO ASAOKA, HIROSHI KAISE, KIMITO YAMADA and TAKASHI ISHIKAWA
    Anticancer Research October 2024, 44 (10) 4525-4536; DOI: https://doi.org/10.21873/anticanres.17281
  • Open Access
    18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer
    YURI KIMURA, SHINSUKE SASADA, AKIKO EMI, NORIO MASUMOTO, TAKAYUKI KADOYA, KOJI ARIHIRO and MORIHITO OKADA
    Anticancer Research January 2023, 43 (1) 127-136; DOI: https://doi.org/10.21873/anticanres.16141
  • Open Access
    Characterization of the Immunological Status of Hypermutated Solid Tumors in the Cancer Genome Analysis Project HOPE
    YASUTO AKIYAMA, RYOTA KONDOU, AKIRA IIZUKA, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, YUJI SHIMODA, KEIICHI OHSHIMA, AKIO SHIOMI, YASUHISA OHDE, MASANORI TERASHIMA, KATSUHIKO UESAKA, YASUYUKI HIRASHIMA, YOSHIO KIYOHARA, HIROHISA KATAGIRI, TAKASHI SUGINO, AKIFUMI NOTSU, KEITA MORI, MITSURU TAKAHASHI, HIROTSUGU KENMOTSU and KEN YAMAGUCHI
    Anticancer Research July 2022, 42 (7) 3537-3549; DOI: https://doi.org/10.21873/anticanres.15840
  • You have access
    A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes
    MORIKAZU MIYAMOTO, TAIRA HADA, HIROKI ISHIBASHI, HIDEKI IWAHASHI, SOICHIRO KAKIMOTO, RIE SUZUKI, TAKAHIRO SAKAMOTO, HIROKO MATSUURA, HITOSHI TSUDA and MASASHI TAKANO
    Anticancer Research February 2021, 41 (2) 1047-1053; DOI: https://doi.org/10.21873/anticanres.14861
  • You have access
    Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer
    SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, NORIO MASUMOTO, TAKAYUKI KADOYA, KOJI ARIHIRO and MORIHITO OKADA
    Anticancer Research June 2020, 40 (6) 3395-3400; DOI: https://doi.org/10.21873/anticanres.14323
  • You have access
    Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    HYUN LEE, MISEON LEE, JEONG-HAN SEO, GYUNGYUB GONG and HEE JIN LEE
    Anticancer Research April 2020, 40 (4) 1883-1890; DOI: https://doi.org/10.21873/anticanres.14142
  • You have access
    Intrinsic Prognostic Impact of Tumor-infiltrating Lymphocytes in Systemically Untreated Patients With Early-stage Triple-negative Breast Cancer
    JI HYUN PARK, HEE JIN LEE, SAE BYUL LEE, JIN-HEE AHN, JEONG EUN KIM, KYUNG HAE JUNG, GYUNGYUB GONG, BYUNG-HO SON, SEI-HYUN AHN and SUNG-BAE KIM
    Anticancer Research June 2019, 39 (6) 3111-3119; DOI: https://doi.org/10.21873/anticanres.13447
  • You have access
    Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma
    HIDEYUKI TAKAHASHI, KOICHI SAKAKURA, YUKIKO ARISAKA, AZUSA TOKUE, KYOICHI KAIRA, HIROE TADA, TETSUYA HIGUCHI, AYAKO OKAMOTO, YOSHITO TSUSHIMA and KAZUAKI CHIKAMATSU
    Anticancer Research June 2019, 39 (6) 3039-3046; DOI: https://doi.org/10.21873/anticanres.13437

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire